首页> 外文期刊>Oncology letters >Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma.
【24h】

Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma.

机译:p53表达水平升高与食管鳞状细胞癌患者的肿瘤进展和不良预后相关。

获取原文
获取原文并翻译 | 示例
           

摘要

Esophageal squamous cell carcinoma (ESCC) is the most common histological subtype of esophageal cancer and one of the most aggressive types of malignancy, with a high rate of mortality. Early diagnosis and treatment may improve the prognosis of ESCC and, thus, survival rates. As a significant tumor suppressor, p53 is closely associated with apoptosis and the differentiation of cancer cells. The present study evaluated the expression levels of the p53 protein and the clinical significance in patients presenting with ESCC. The p53 protein expression level of 64 paired ESCC and tumor-adjacent normal tissues was evaluated using western blot analysis. In addition, immunohistochemistry (IHC) was performed to detect the p53 expression level in specimens from 118 paraffin-embedded cancerous tissues. The correlation of the p53 expression level with the clinicopathological parameters and prognosis of the ESCC patients was also analyzed. The p53 protein was identified to be highly expressed in the ESCC tissue, with western blot analysis demonstrating that the expression level of p53 in the cancerous tissue was 1.89 times that of the tumor-adjacent normal tissue (P<0.001); furthermore, IHC indicated that there was a marked positive expression of p53 in the ESCC tissue (49.15%). The expression level of p53 protein was identified to be significantly correlated with the tumor grade (P<0.001), N stage (P=0.010). Additionally, the higher level of p53 expression was found to be associated with a poor survival rate in the ESCC patients (P=0.0404). The univariate analysis showed that the survival time of patients was significantly correlated with the T stage (RR=3.886, P<0.001), N stage (lymph node metastasis; RR=3.620, P<0.001) and TNM stage (RR=3.576, P<0.001). Furthermore, the multivariate analysis revealed that the T stage (RR=3.988, P<0.001) and N stage (RR=4.240, P=0.004) significantly influenced the overall survival of the ESCC patients.
机译:食管鳞状细胞癌(ESCC)是食管癌的最常见组织学亚型,也是恶性程度最高的恶性肿瘤之一,死亡率很高。早期诊断和治疗可以改善ESCC的预后,从而提高生存率。作为重要的肿瘤抑制因子,p53与细胞凋亡和癌细胞的分化密切相关。本研究评估了pCC蛋白的表达水平及其在ESCC患者中的临床意义。使用蛋白质印迹分析评估64对配对的ESCC和邻近肿瘤的正常组织的p53蛋白表达水平。另外,进行了免疫组织化学(IHC)检测来自118个石蜡包埋的癌组织标本中的p53表达水平。还分析了p53表达水平与ESCC患者的临床病理参数和预后的关系。经鉴定,p53蛋白在ESCC组织中高表达,Western印迹分析表明,癌组织中p53的表达水平是癌旁正常组织的1.89倍(P <0.001)。此外,IHC还表明在食管鳞癌组织中p53有明显的阳性表达(49.15%)。鉴定出p53蛋白的表达水平与肿瘤等级(P <0.001),N期(P = 0.010)显着相关。另外,发现较高的p53表达水平与ESCC患者的不良存活率有关(P = 0.0404)。单因素分析表明,患者的生存时间与T期(RR = 3.886,P <0.001),N期(淋巴结转移; RR = 3.620,P <0.001)和TNM期(RR = 3.576, P <0.001)。此外,多变量分析显示,T期(RR = 3.988,P <0.001)和N期(RR = 4.240,P = 0.004)显着影响ESCC患者的整体生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号